Chapter 4

Neurochemistry and Neuropharmacology of Essential Tremor

Hortensia Alonso-Navarro, Félix Javier Jiménez-Jiménez, Elena García- Martín and José A.G. Agúndez

Abstract

The neurochemical mechanisms for essential tremor are unknown, as there is no good experimental model for this disease and only a few post-mortem studies have been reported. Alterations of the dopaminergic, serotonergic, GABAergic, noradrenergic and adrenergic systems have been described, and are the object of this revision. The most consistent data are related with the GABAergic, dopaminergic and adrenergic systems. The pharmacological treatments that have demonstrated greatest efficacy for essential tremor are the beta-blockers propranolol and primidone. The efficacy of other drugs, such as antiepileptic drugs, calcium antagonists, amantadine, clozapine, olanzapine, alprazolam, theophylline, etc., has not been clearly demonstrated. In some cases resistant to pharmacotherapy, infiltrations with botulinum toxin type A have been described as effective.

Total Pages: 110-142 (33)

Purchase Chapter  Book Details

RELATED BOOKS

.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Traditional Medicine for Neuronal Health.
.Recent Advances in the Treatment of Neurodegenerative Disorders.
.Alzheimer
.Advances in Alzheimer Research.